Hypophosphatasia Hpp clinical trials

Explore recruiting hypophosphatasia hpp clinical trials.

Recruiting hypophosphatasia hpp studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hypophosphatasia Hpp trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomised, Placebo-Controlled, Double-Blind, Single-Ascending Dose and Multiple-Ascending Dose First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered ALE1 With or Without Food in Healthy Adult Participants and Adult Patients With Hypophosphatasia

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Open-Label Pilot Trial to Evaluate the Effects of Ilofotase Alfa on Biomarkers in Adult Patients with Hypophosphatasia

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 3, Randomized, Open-label, Parallel-arm, Active-controlled, Multicenter Study to Evaluate Safety and Efficacy of ALXN1850 Versus Asfotase Alfa Administered Subcutaneously in Pediatric Participants (2 to < 12 years of age) with Hypophosphatasia (HPP) Previously Treated with Asfotase Alfa (Chestnut)

Italy, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hypophosphatasia Hpp trials by city

Hypophosphatasia Hpp in Toronto Hypophosphatasia Hpp in Vancouver Hypophosphatasia Hpp in Montreal Hypophosphatasia Hpp in Calgary Hypophosphatasia Hpp in Edmonton Hypophosphatasia Hpp in Ottawa Hypophosphatasia Hpp in Winnipeg Hypophosphatasia Hpp in Quebec City Hypophosphatasia Hpp in Hamilton Hypophosphatasia Hpp in Kitchener Hypophosphatasia Hpp in London Hypophosphatasia Hpp in Halifax Hypophosphatasia Hpp in New York Hypophosphatasia Hpp in Los Angeles Hypophosphatasia Hpp in Chicago Hypophosphatasia Hpp in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease